• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见的原发性皮肤滤泡中心淋巴瘤病例,表现为头皮巨大肿瘤,并伴有 JAK2V617F 阳性原发性血小板增多症。

A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia.

机构信息

Department of Haematology, University Hospital of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland.

出版信息

Biomark Res. 2014 Apr 1;2(1):7. doi: 10.1186/2050-7771-2-7.

DOI:10.1186/2050-7771-2-7
PMID:24690328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3978001/
Abstract

Primary cutaneous follicle centre lymphoma (PCFCL) is a rare cutaneous B cell lymphoma in middle-age adults with excellent prognosis. Here we present a case of a patient with a PCFCL in the form of a giant tumour of the scalp in combination with a myeloproliferative neoplasm, JAK2V617F positive essential thrombocythaemia. This case may be of interest because of the favourable outcome in spite of the large size of the PCFCL, the rare combination with essential thrombocythaemia and because it contributes to discussion on the role of JAK2 mutation in such patients.

摘要

原发性皮肤滤泡中心淋巴瘤(PCFCL)是一种罕见的中老年人皮肤 B 细胞淋巴瘤,预后良好。在此,我们报告了一例 PCFCL 患者,其头皮巨大肿瘤合并骨髓增殖性肿瘤、JAK2V617F 阳性原发性血小板增多症。本病例可能具有临床意义,因为尽管 PCFCL 体积较大、罕见合并原发性血小板增多症,但患者预后良好,并且有助于讨论 JAK2 突变在这类患者中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3978001/4cd6bcc0349e/2050-7771-2-7-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3978001/18cc711b061e/2050-7771-2-7-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3978001/07434b29969f/2050-7771-2-7-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3978001/4cd6bcc0349e/2050-7771-2-7-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3978001/18cc711b061e/2050-7771-2-7-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3978001/07434b29969f/2050-7771-2-7-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3978001/4cd6bcc0349e/2050-7771-2-7-3.jpg

相似文献

1
A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia.罕见的原发性皮肤滤泡中心淋巴瘤病例,表现为头皮巨大肿瘤,并伴有 JAK2V617F 阳性原发性血小板增多症。
Biomark Res. 2014 Apr 1;2(1):7. doi: 10.1186/2050-7771-2-7.
2
Epstein-Barr virus-positive primary cutaneous follicle centre lymphoma; an age-related phenomenon?爱泼斯坦-巴尔病毒阳性原发性皮肤滤泡中心淋巴瘤;一种与年龄相关的现象?
Virchows Arch. 2015 Jul;467(1):111-7. doi: 10.1007/s00428-015-1779-7. Epub 2015 May 10.
3
Unusual Clinical Presentation of a Primary Cutaneous Follicle Center Lymphoma on the Scalp of a Middle-Aged Female: Case Report and Review of the Literature.中年女性头皮原发性皮肤滤泡中心淋巴瘤的不寻常临床表现:病例报告及文献复习
Skin Appendage Disord. 2019 Nov;5(6):379-385. doi: 10.1159/000501174. Epub 2019 Jul 2.
4
Primary cutaneous follicle center lymphoma of the breast: Management of an exceedingly rare malignancy.乳腺原发性皮肤滤泡中心淋巴瘤:一种极其罕见恶性肿瘤的管理
Intractable Rare Dis Res. 2020 Nov;9(4):263-265. doi: 10.5582/irdr.2020.03095.
5
A Case of Transformation of Primary Cutaneous Follicle Center Lymphoma to Diffuse Large B-Cell Lymphoma Involving the Parotid Gland and Cervical Lymph Nodes.一例原发性皮肤滤泡中心淋巴瘤转化为累及腮腺和颈部淋巴结的弥漫性大B细胞淋巴瘤病例。
Am J Case Rep. 2019 Aug 29;20:1273-1278. doi: 10.12659/AJCR.917389.
6
Atypical clinical presentation of primary and secondary cutaneous follicle center lymphoma (FCL) on the head characterized by macular lesions.头面部原发性和继发性皮肤滤泡中心淋巴瘤(FCL)的非典型临床表现为斑片状损害。
J Am Acad Dermatol. 2016 Nov;75(5):1000-1006. doi: 10.1016/j.jaad.2016.05.039. Epub 2016 Jul 2.
7
Enigmatic Presentation of Primary Cutaneous Lymphoma in a Boy.一名男孩原发性皮肤淋巴瘤的神秘表现
Plast Reconstr Surg Glob Open. 2024 Sep 6;12(9):e6150. doi: 10.1097/GOX.0000000000006150. eCollection 2024 Sep.
8
Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.原发性皮肤 B 细胞淋巴瘤和正常 B 细胞库中 B 细胞受体的获得性 N-连接糖基化基序。
J Invest Dermatol. 2019 Oct;139(10):2195-2203. doi: 10.1016/j.jid.2019.04.005. Epub 2019 Apr 28.
9
Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.凋亡基因分析可识别原发性皮肤大B细胞淋巴瘤的不同类型。
J Pathol. 2008 Jul;215(3):340-6. doi: 10.1002/path.2374.
10
Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.原发性皮肤滤泡中心细胞淋巴瘤的染色体异常并不预示预后不良。
J Am Acad Dermatol. 2014 Jun;70(6):1010-20. doi: 10.1016/j.jaad.2014.01.862. Epub 2014 Mar 26.

引用本文的文献

1
Scalp Involvement in Primary Cutaneous Lymphomas-An Update on Clinical Presentation, Diagnostics, and Management.原发性皮肤淋巴瘤的头皮受累——临床表现、诊断及管理的最新进展
Cancers (Basel). 2025 May 16;17(10):1678. doi: 10.3390/cancers17101678.

本文引用的文献

1
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application.JAK-STAT 通路在血液系统恶性肿瘤中的失调及 JAK 抑制剂的临床应用。
Biomark Res. 2013 Jan 16;1(1):5. doi: 10.1186/2050-7771-1-5.
2
Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib.针对淋巴瘤中的 JAK-STAT 通路:聚焦帕克里替尼。
Expert Opin Investig Drugs. 2013 Jun;22(6):775-85. doi: 10.1517/13543784.2013.775244. Epub 2013 Feb 26.
3
Investigational Janus kinase inhibitors.研究性 Janus 激酶抑制剂。
Expert Opin Investig Drugs. 2013 Jun;22(6):687-99. doi: 10.1517/13543784.2013.774373. Epub 2013 Feb 23.
4
JAKs and STATs in immunity, immunodeficiency, and cancer.免疫、免疫缺陷和癌症中的JAKs与STATs
N Engl J Med. 2013 Jan 10;368(2):161-70. doi: 10.1056/NEJMra1202117.
5
Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms.同时性和序贯性骨髓和淋巴增生性肿瘤。
Acta Haematol. 2013;129(3):187-96. doi: 10.1159/000342484. Epub 2012 Dec 21.
6
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.一项新型口服 Janus 激酶 2 抑制剂 SB1518 治疗复发淋巴瘤患者的 I 期研究:多种淋巴瘤亚型的临床和生物学活性证据。
J Clin Oncol. 2012 Nov 20;30(33):4161-7. doi: 10.1200/JCO.2012.42.5223. Epub 2012 Sep 10.
7
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.慢性淋巴细胞白血病与骨髓增生性肿瘤共存:GIMEMA 的回顾性多中心经验。
Am J Hematol. 2011 Dec;86(12):1007-12. doi: 10.1002/ajh.22171. Epub 2011 Sep 22.
8
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.骨髓增生性肿瘤患者的淋巴肿瘤风险增加:一项对 1915 名患者的研究。
Haematologica. 2011 Mar;96(3):454-8. doi: 10.3324/haematol.2010.033779. Epub 2010 Nov 25.
9
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.整合分析揭示了结节性硬化性霍奇金淋巴瘤和原发性纵隔大 B 细胞淋巴瘤中 9p24.1 选择性扩增、PD-1 配体表达增加以及 JAK2 进一步诱导。
Blood. 2010 Oct 28;116(17):3268-77. doi: 10.1182/blood-2010-05-282780. Epub 2010 Jul 13.
10
Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.费城染色体阴性骨髓增殖性肿瘤患者发生淋巴样肿瘤的风险增加。
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2068-73. doi: 10.1158/1055-9965.EPI-09-0353. Epub 2009 Jun 16.